(Q40953808)

25 September 2017

title

Phase I clinical evaluation of anguidine (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A361224

26 June 2022

author name string

W. K. Murphy

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A361224

26 June 2022

M. A. Burgess

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A361224

26 June 2022

M. Valdivieso

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A361224

26 June 2022

R. B. Livingston

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A361224

26 June 2022

G. P. Bodey

5

0 references

E. J. Freireich

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A361224

26 June 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=361224

26 June 2022

publication date

1 October 1978

1 reference

25 September 2017

published in

Cancer Treatment Reports

1 reference

25 September 2017

volume

62

1 reference

25 September 2017

issue

10

1 reference

25 September 2017

page(s)

1497-1502

1 reference

25 September 2017

Identifiers

1 reference